Standard Biotools Stock Technical Analysis
| LAB Stock | USD 1.26 0.02 1.61% |
As of the 6th of February, Standard Biotools has the Semi Deviation of 3.35, coefficient of variation of 3105.47, and Risk Adjusted Performance of 0.0325. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Standard Biotools, as well as the relationship between them.
Standard Biotools Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Standard, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to StandardStandard Biotools' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Standard Biotools Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 1.55 | Strong Buy | 3 | Odds |
Most Standard analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Standard stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Standard Biotools, talking to its executives and customers, or listening to Standard conference calls.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. Expected growth trajectory for Standard significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Standard Biotools assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.38) | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets | Return On Equity |
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Standard Biotools' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Standard Biotools represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Standard Biotools' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Standard Biotools 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Standard Biotools' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Standard Biotools.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Standard Biotools on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Standard Biotools or generate 0.0% return on investment in Standard Biotools over 90 days. Standard Biotools is related to or competes with Varex Imaging, CeriBell, Cullinan Oncology, Avanos Medical, So Young, ADC Therapeutics, and Treace Medical. Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researche... More
Standard Biotools Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Standard Biotools' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Standard Biotools upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.68 | |||
| Information Ratio | 0.022 | |||
| Maximum Drawdown | 25.5 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.81 |
Standard Biotools Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Standard Biotools' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Standard Biotools' standard deviation. In reality, there are many statistical measures that can use Standard Biotools historical prices to predict the future Standard Biotools' volatility.| Risk Adjusted Performance | 0.0325 | |||
| Jensen Alpha | 0.0849 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.0263 | |||
| Treynor Ratio | 0.0986 |
Standard Biotools February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0325 | |||
| Market Risk Adjusted Performance | 0.1086 | |||
| Mean Deviation | 3.09 | |||
| Semi Deviation | 3.35 | |||
| Downside Deviation | 3.68 | |||
| Coefficient Of Variation | 3105.47 | |||
| Standard Deviation | 4.4 | |||
| Variance | 19.39 | |||
| Information Ratio | 0.022 | |||
| Jensen Alpha | 0.0849 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.0263 | |||
| Treynor Ratio | 0.0986 | |||
| Maximum Drawdown | 25.5 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.81 | |||
| Downside Variance | 13.53 | |||
| Semi Variance | 11.25 | |||
| Expected Short fall | (3.92) | |||
| Skewness | 1.43 | |||
| Kurtosis | 6.04 |
Standard Biotools Backtested Returns
At this point, Standard Biotools is dangerous. Standard Biotools owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0428, which indicates the firm had a 0.0428 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Standard Biotools, which you can use to evaluate the volatility of the company. Please validate Standard Biotools' Risk Adjusted Performance of 0.0325, coefficient of variation of 3105.47, and Semi Deviation of 3.35 to confirm if the risk estimate we provide is consistent with the expected return of 0.19%. Standard Biotools has a performance score of 3 on a scale of 0 to 100. The entity has a beta of 1.34, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Standard Biotools will likely underperform. Standard Biotools right now has a risk of 4.51%. Please validate Standard Biotools jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to decide if Standard Biotools will be following its existing price patterns.
Auto-correlation | 0.14 |
Insignificant predictability
Standard Biotools has insignificant predictability. Overlapping area represents the amount of predictability between Standard Biotools time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Standard Biotools price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Standard Biotools price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Standard Biotools technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Standard Biotools Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Standard Biotools volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Standard Biotools Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Standard Biotools on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Standard Biotools based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Standard Biotools price pattern first instead of the macroeconomic environment surrounding Standard Biotools. By analyzing Standard Biotools's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Standard Biotools's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Standard Biotools specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 6.05 | 7.34 | 6.61 | 5.2 | Days Of Inventory On Hand | 134.09 | 164.9 | 189.63 | 196.27 |
Standard Biotools February 6, 2026 Technical Indicators
Most technical analysis of Standard help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Standard from various momentum indicators to cycle indicators. When you analyze Standard charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0325 | |||
| Market Risk Adjusted Performance | 0.1086 | |||
| Mean Deviation | 3.09 | |||
| Semi Deviation | 3.35 | |||
| Downside Deviation | 3.68 | |||
| Coefficient Of Variation | 3105.47 | |||
| Standard Deviation | 4.4 | |||
| Variance | 19.39 | |||
| Information Ratio | 0.022 | |||
| Jensen Alpha | 0.0849 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.0263 | |||
| Treynor Ratio | 0.0986 | |||
| Maximum Drawdown | 25.5 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.81 | |||
| Downside Variance | 13.53 | |||
| Semi Variance | 11.25 | |||
| Expected Short fall | (3.92) | |||
| Skewness | 1.43 | |||
| Kurtosis | 6.04 |
Standard Biotools February 6, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Standard stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 42,262 | ||
| Daily Balance Of Power | 0.40 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 1.27 | ||
| Day Typical Price | 1.27 | ||
| Price Action Indicator | (0.01) |
Complementary Tools for Standard Stock analysis
When running Standard Biotools' price analysis, check to measure Standard Biotools' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Biotools is operating at the current time. Most of Standard Biotools' value examination focuses on studying past and present price action to predict the probability of Standard Biotools' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Biotools' price. Additionally, you may evaluate how the addition of Standard Biotools to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |